Form D · Biotechnology
MiniVax, Inc.
New Orleans, LA · CIK 0001572556
Offering snapshot reported May 2, 2013 · SEC filing
- Reported sold
- $110K Offering amount: $1.5M
- Investors reported
- 4 Form D · investor count
- Minimum accepted
- $10K Reported outside-investor minimum
- First sale
- May 2, 2013 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 2, 2013 | Initial | $110,000 | No comparison | 4 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-195920
Source: Form D, filed May 2, 2013. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Douglas Carnes | Executive |
| A. Ray Chaudhuri | Director, Executive |
| Sandra Coufal | Director |
| Martha Sue Preston | Director, Executive |
| Martin Preuveneers | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
1441 Canal Street Suite 314
New Orleans, LA, 70112
New Orleans, LA, 70112